The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) Study is the Largest U.S.-Based Prospective Study Demonstrating a Circulating Fetal Cell (CFC) Based Approach to Non-invasive Fetal Risk Assessment
N/A
The goal of the ADVANCE (Assay Development and Validation for Pre-Natal and...
Status
Recruiting
Location
Valley Perinatal Services
Start Date
2026-01-10
Trial ID
NCT07643896
First Trimester Risk Assessment Based on Ultrasound and Cell-free DNA vs Combined Screening
NA
There is an ongoing debate regarding how cell-free DNA (cfDNA) screening ca...
Parallel Sequencing of Fetal Genome and RNA in the Presence of Ultrasound Warning Signs: a Complementary Approach for the Prenatal Diagnosis of Rare Diseases.
N/A
Prenatal exome sequencing (ES) is increasingly used for fetuses with ultras...